Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 153

MOTION to Strike Roche's Affirmative Defenses Nos. 2, 7, 8, 10 and 12 by Amgen Inc..(Gottfried, Michael)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 153

Case 1:05-cv-12237-WGY

Document 153

Filed 11/27/2006

Page 1 of 3

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ) ) ) Plaintiff, ) ) Civil Action No.: 05-12237 WGY v. ) ) ) F. HOFFMANN-LA ROCHE ) LTD., a Swiss Company, ROCHE ) DIAGNOSTICS GmbH, a German ) Company and HOFFMANN-LA ROCHE ) INC., a New Jersey Corporation, ) ) Defendants. ) __________________________________________) AMGEN INC., AMGEN INC.'S MOTION TO STRIKE ROCHE'S AFFIRMATIVE DEFENSES NOS. 2, 7, 8, 10, AND 12 For the reasons set forth in its supporting Memorandum, filed herewith, Plaintiff Amgen Inc. ("Amgen") submits this motion to strike under FED. R. CIV. P. 12(f) the 2nd, 7th, 8th, 10th, and 12th Affirmative Defenses of Defendants F. Hoffmann-La Roche, Ltd., Roche Diagnostics GmbH, and Hoffmann-La Roche Inc. (collectively "Roche"). Accordingly, Amgen respectfully requests that the Court order: 1. 2. Roche's 2nd, 7th, 8th, 10th, and 12th Affirmative Defenses be stricken; and Should Roche be permitted an opportunity to amend its Answer, that Roche: (a) specify "the who, what, when, where, and how" of all alleged misrepresentations and omissions in the manner set forth in Amgen's Memorandum; (b) identify all specific acts upon which Roche bases its inequitable conduct defense;

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 153

Filed 11/27/2006

Page 2 of 3

(c) identify all relevant differences, if any, between its current inequitable conduct allegations and those encompassed by Amgen Inc. v. Hoechst Marion Roussel, Inc., 126 F. Supp. 2d 69, 141-45 (D. Mass. 2001), aff'd in pertinent part, 314 F.3d 1313, 1357-58 (Fed. Cir. 2003); (d) identify all factual allegations supporting the elements of its unclean hands and patent misuse defenses; and (e) state whether, and if so how, its unclean hands and misuse defenses are based on inequitable conduct. Dated: November 27, 2006 Respectfully S u b m i t t e d , AMGEN INC., By its attorneys, /s/ Michael R. Gottfried D. Dennis Allegretti (BBO#545511) Michael R. Gottfried (BBO# 542156) Patricia R. Rich (BBO# 640578) DUANE MORRIS LLP 470 Atlantic Avenue, Suite 500 Boston, MA 02210 Telephone: [phone] Facsimile: [phone] Lloyd R. Day, Jr. David M. Madrid Linda A. Sasaki-Baxley DAY CASEBEER, MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Suite 400 Cupertino, CA 95014 Telephone: [phone] Facsimile: [phone] William Gaede III McDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Telephone: [phone] Facsimile: [phone] Michael F. Borun Kevin Flowers MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago, IL 60606 Telephone: [phone] Facsimile: [phone]

Of Counsel: Stuart L. Watt Wendy A. Whiteford Monique L. Cordray Darrell G. Dotson MarySusan Howard Kimberlin L. Morley AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1789 [phone]

2

Case 1:05-cv-12237-WGY

Document 153

Filed 11/27/2006

Page 3 of 3

CERTIFICATE PURSUANT TO LOCAL RULE 7.1 I certify that counsel for the Plaintiff has attempted to confer with counsel for the Defendants, F. Hoffman-LaRoche Ltd., Hoffman LaRoche Inc. and Roche Diagnostics GmbH, in an attempt to resolve or narrow the issues presented by this motion and that no agreement could be reached. /s/ Michael R. Gottfried Michael R. Gottfried

CERTIFICATE OF SERVICE I hereby certify that this document, filed through the ECF system, will be sent electronically to the registered participants as identified on the Notice of Electronic Filing and paper copies will be sent to those indicated as non registered participants on November 27, 2006.

/s/ Michael R. Gottfried Michael R. Gottfried

3